Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

With Sun Pharmaceutical Industries currently trading at Rs 1786.50, the stock has demonstrated strong momentum, supported by ...

Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

TBO Tek Ltd witnessed volume of 73.49 lakh shares by 10:48 IST on BSE, a 1532.19 times surge over two-week average daily volume of 4797 shares. The stock dropped 4.48% to Rs.1,213.00. Volumes stood at ...

Eli Lilly launches Mounjaro in India addressing diabetes-obesity crisis. Approved by CDSCO yet high costs limit accessibility ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Sun Pharma Share Price Live Updates: Sun Pharma's closing price today is Rs 1754.0, reflecting a gain. Sun Pharma closed at Rs 1754.0 today, indicating a rise of 1.25%. Sun Pharma is currently priced ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

TAOISEACH Micheal Martin has warned that people in America will face even higher medicine prices if Donald Trump hits Ireland ...